Meril receives ICMR approval for indigenous Covid-19 Self-Test, CoviFind

FPJ BureauUpdated: Friday, June 18, 2021, 12:49 PM IST
article-image

Global medtech company Meril, based in Vapi, Gujarat, has announced its self-use Rapid Antigen Test for Covid-19, CoviFind, has received approval from the Indian Council of Medical Research (ICMR). This indigenously researched and developed test can detect the SARS-CoV-2 virus reliably in infectious individuals and can therefore be used for testing symptomatic individuals and immediate contacts of confirmed coronavirus cases as specified by recent ICMR guidelines.

Meril’s home-use rapid antigen tests will expand access to Covid-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of Covid-19. The provision of high-quality rapid antigen testing will also enable access to screening in previously out-of-reach or under-equipped areas.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Gurdeep Singh, CMD NTPC wins S&P Platts Global CEO of the year Award

Gurdeep Singh, CMD NTPC wins S&P Platts Global CEO of the year Award

Stella Maris College launches Tamil Nadu SDG Girls Championship 2022

Stella Maris College launches Tamil Nadu SDG Girls Championship 2022

Pottery Barn signs Deepika Padukone as brand ambassador

Pottery Barn signs Deepika Padukone as brand ambassador

HIV/AIDS awareness rally by Saveetha Dental College and Hospitals, and Red Ribbon Club, SIMATS

HIV/AIDS awareness rally by Saveetha Dental College and Hospitals, and Red Ribbon Club, SIMATS

GAIL wins best ‘Energy Transition – Midstream Company’ award

GAIL wins best ‘Energy Transition – Midstream Company’ award